Abstracts

The Conference Secretariat and Scientific Committees encourages abstract submission for the poster session in a broad range of cancer related topics.

Abstract submission guidelines are listed below.

Abstract submission 

The deadline for abstract submission is 27.3.2018
Abstracts should be submitted only through the website. Any other method will not be considered. Please read the rules of submission before submitting your abstract. 


The Scientific Committee will review all the abstracts. Some abstracts will be selected for an oral presentation given by the first author. Notification of acceptance for an oral presentation will be sent no later then April 22nd. 

Should you encounter any difficulties, please do not hesitate to contact the conference secretariat via email: CBRC2018@kenes-events.com

Instruction for Abstract Submission:

  • The Scientific Committee will review all the abstracts, and once complete, the abstract submitter will be notified whether the abstract was selected for an oral presentation.​
  • All abstracts must be submitted and presented in English and spelled in publication quality.
  • Upon submission, the Abstract Submitter confirms that the abstract has been revised and that all information is correct. The content of this abstract cannot be modified or corrected after final submission and the author is aware that it will be published exactly as submitted.
  • The abstract submission constitutes acceptance of the authors regarding its publication (e.g. conference website, programs, conference Facebook page, other promotions, etc.).
  • The Abstract Submitter warrants and represents that he/she is the exclusive owner or has the rights of all the information and content (Hereafter: “Content”) provided to The 18th CBRC Biennial Meeting and Kenes Israel (Hereafter: “The Organizers”). The publication of the abstract does not infringe any third party rights including, but not limited to, intellectual property rights.
  • Submitted abstracts containing research by clinical trials on human or animal subjects must be approved by the Helsinki Committee or by the local Institutional Review Board.
  • Abstracts can only be submitted by a student or scientist / clinician at Tel Aviv University and the affiliated medical centers. Names of the collaborator scientists  cannot appear as first authors in studies conducted in collaboration with another research institute.  
  • The organizers have the right to remove any abstract which does not comply with the above.
  • Upon submission the Abstract Submitter confirms that the contact details saved in the system are those of the corresponding author, who will be notified about the status of the abstract, and will be responsible for informing the other authors about the status of the abstract.
  • For participants submitting abstracts, payment will only be taken following the scientific committee's selection of submitted abstracts for oral or poster presentation.


Guidelines for Abstract Submission

Before you begin, please prepare the following information:

Presenting author’s contact details 
Title, full first and last name(s)
Affiliation details: department, institution / hospital, city, state (if relevant), country
Email address
Daytime and evening phone number

Author and co-authors’ details
Title, full first and last name(s)
Affiliation details: department, institution / hospital, city, state (if relevant), country

Abstract Title – limited to 25 words in UPPER CASE
Abstract Body – limited to 300 words
No figures, diagrams or frames are acceptable.


Abstract Layout – abstracts should use the following structured format:
Introduction/ Background
Methods/ Materials
Results
Conclusions

Abstract categories include:
 
HEMATOLOGICAL MALIGNANCIES
CANCER DIAGNOSTICS AND THERAPY
IMMUNE-ONCOLOGY
NEURO-ONCOLOGY
TUMOR MICRO-ENVIRONMENT
PERSONALIZED MEDICINE
COMPUTATIONAL ANALYSIS & MATCHING TECHNOLOGIES

​OTHER

Please make sure to follow instructions before submitting an abstract